Relay Therapeutics, Inc. (NASDAQ:RLAY) to Post FY2025 Earnings of ($3.10) Per Share, HC Wainwright Forecasts
Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) – Analysts at HC Wainwright issued their FY2025 earnings per share estimates for Relay Therapeutics in a report released on Friday, June 7th. HC Wainwright analyst R. Burns expects that the company will earn ($3.10) per share for the year. HC Wainwright has a “Buy” rating and a […]
More Stories
SBA Refers 562,000 Suspected Fraudulent Loans Worth $22.2 Billion to Treasury
By Naveen Athrappully The Small Business Administration (SBA) has referred 562,000 loans suspected to be fraudulent to the Treasury Department...
US Exports of Crude and Petroleum Products Hit Record Highs
By Jacki Thrapp America’s energy exports have hit record highs as the world navigates the uncertainty surrounding oil and gas...
New Listings Tick Up 3 Percent as Mortgage Rates Continue to Slide
By Rob Sabo New home listings are on the rise across the United States, potentially spurred by hopes of falling...
US, EU Sign Preliminary Partnership Deal on Critical Minerals
By Owen Evans The United States and the European Union signed a memorandum of understanding on April 24 for a...
DOJ Approves Firing Squads for Federal Death Penalty Cases
By Michael Clements The Department of Justice (DOJ) has authorized firing squads, electrocution, and gassing as a means of execution...
Trump Extends Jones Act Waiver for 90 Days to Ease Energy Crunch
By Tom Ozimek President Donald Trump has extended a waiver of the century-old Jones Act for 90 days, allowing foreign-flagged...